Tirzepatide (Mounjaro) : A dual-action medication that targets both GLP-1 and GIP receptors, demonstrating remarkable results in weight loss and glucose control
The studies conducted by Mansur et al 23 and Li et al 22 and their respective findings on liraglutides effect on cognitive function are promising, as they observed improvements in cognitive scores and memory, along with enhanced brain activation, indicating the potential neurocognitive benefits of GLP-1 agonists
The same is true with weight loss from GLP-1 agonists
If you notice fatigue, flu-like symptoms, or any other worsening of symptoms after you begin using liposomal glutathione, you can lower your dose or back off completely until the symptoms subside
Head-to-Head: Efficacy Comparison Neither agent has been compared directly in a randomized controlled trial
Available from: Ahmadi H, Fotesko K, Ba-Ali S, Hamann S, Kolko M